腎臓および泌尿器機器の世界市場分析:タイプ別(透析、尿石、尿管ステント、石灰化装置、尿失禁および骨盤臓器脱落、仙骨神経調節、膣メッシュおよびスリング、尿道挿入物およびペッサリー、良性前立腺肥大症、カテーテルアブレーション、前立腺ステント、内視鏡)、セグメント予測

◆英語タイトル:Nephrology And Urology Devices Market Analysis By Type (Dialysis, Urinary Stone, Ureteral Stents, Lithotripters, Urinary Incontinence & Pelvic Organ Prolapse, Sacral Neuromodulation, Vaginal Meshes & Slings, Urethral Inserts & Pessaries, Benign Prostatic Hyperplasia, Catheter Ablation, Prostatic Stents, Endoscopy), And Segment Forecasts to 2024
◆商品コード:GVIEW707577
◆発行会社(調査会社):Grand View Research
◆発行日:2016年8月9日
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥559,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,124,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、腎臓および泌尿器機器の世界市場について調査・分析し、腎臓および泌尿器機器の世界市場動向、腎臓および泌尿器機器の世界市場規模、市場予測、セグメント別腎臓および泌尿器機器市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global nephrology and urology devices market is expected to reach USD 31.3 billion by 2024, according to a new study by Grand View Research, Inc. The market is driven by technological advancements that are anticipated to serve the market with future growth opportunities. These advancements include inclusion of stem cells, wearable artificial kidneys, combined use of ion-sensitive sensors & electrodes, living membranes, shockwave, and laser lithotripsy.
These technologies serve as efficient methods of renal care, which are capable of improving overall patient health and quality of life. In addition, improved uremic toxin and fluid removal, relatively less hypotension episodes, better control of blood pressure, overall improvement in mineral metabolism, better survival rate, and reduction in hospitalization rates & costs. In addition, these advancements also have a substantial impact on patient’s quality of life through increased volume of dialysate, ultrafiltration capacity, and higher solute clearance.

The unprecedented adoption of unhealthy lifestyle has exerted a major impact on the market, leading to high prevalence of chronic diseases, such as cancer and diabetes, which serve as a contributing factor toward developing kidney and urinary diseases. Moreover, the widening of geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases is expected to impel the demand for highly efficient devices.

Furthermore, increasing geographical presence of major market players is expected to raise the levels of awareness pertaining to advanced technologies available for treatment in emerging economies, thus impelling the market growth throughout the forecast period. In addition, increasing participation in research studies to further improve these devices is expected to propel high scale growth for this market during the forecast period.

Further Key Findings from the Study Suggest:

The dialysis devices in the product segment held a dominant share in 2015. This is a consequence of the high clinical urgency to curb the unprecedented growth in renal failure globally. Moreover, easy availability and presence of a wide-scale portfolio in the global market is facilitating a higher penetration of dialysis devices, thus resulting in a higher share

In 2015, Europe dominated the overall nephrology and urology devices market with a share of over 40.0%. The increasing number of product approvals by healthcare organizations and presence of large patient volume requiring dialysis across this region are anticipated to be a contributing factor toward substantial share

Asia Pacific is anticipated to witness at a lucrative CAGR of over 7.0% during the forecast period. This can be attributed to rising per capita healthcare spending and increasing availability of minimally invasive devices & awareness pertaining to the, amongst patient base present across the region

The dominant players are indulging into collaborative strategies and new product development in order to capture a larger share of the market. The increasing number of mergers & acquisitions are believed to strengthen the competitive scenario of nephrology and urology market

For instance, in September 2013, Baxter International, Inc. acquired Gambro AB, a dialysis products manufacturer, to facilitate expansion and enhancement of renal therapy product portfolio, in order to gain a competitive advantage over other players

【レポートの目次】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & growth prospect mapping
4.5. Nephrology and urology Competitive Landscape, 2015
4.5.1. Company market share analysis
4.5.2. Competitive landscape: market position analysis
4.6. Nephrology and urology devices-SWOT Analysis, By Factor (political & legal, economic and technological)
4.7. Industry Analysis – Porter’s
Chapter 5. Market Categorization 1: Type Estimates & Trend Analysis
5.1. Nephrology and urology devices Market: Type movement analysis
5.2. Dialysis
5.2.1. Dialysis market estimates and forecasts, 2013 – 2024 (USD Billion)
5.3. Urinary Stone
5.3.1. Urinary stone market estimates and forecasts, 2013 – 2024 (USD Billion)
5.3.2. Ureteral Stents
5.3.2.1. Ureteral stents market estimates and forecasts, 2013 – 2024 (USD Billion)
5.3.3. Lithotripters
5.3.3.1. Lithotripters market estimates and forecasts, 2013 – 2024 (USD Billion)
5.4. Urinary Incontinence & Pelvic Organ Prolapse
5.4.1. Urinary incontinence & pelvic organ prolapse market estimates and forecasts, 2013 – 2024 (USD Billion)
5.4.2. Sacral Neuromodulation
5.4.2.1. Sacral neuromodulation market estimates and forecasts, 2013 – 2024 (USD Billion)
5.4.3. Vaginal Meshes & Slings
5.4.3.1. Vaginal meshes & slings market estimates and forecasts, 2013 – 2024 (USD Billion)
5.4.4. Urethral Inserts & Pessaries
5.4.4.1. Urethral inserts & pessaries market estimates and forecasts, 2013 – 2024 (USD Billion)
5.5. Benign Prostatic Hyperplasia
5.5.1. Benign prostatic hyperplasia market estimates and forecasts, 2013 – 2024 (USD Billion)
5.5.2. Catheter Ablation
5.5.2.1. Catheter ablation market estimates and forecasts, 2013 – 2024 (USD Billion)
5.5.3. Prostatic Stents
5.5.3.1. Prostatic stents market estimates and forecasts, 2013 – 2024 (USD Billion)
5.5.4. Endoscopy
5.5.4.1. Endoscopy market estimates and forecasts, 2013 – 2024 (USD Billion)
5.5.5. Others
5.5.5.1. Others market estimates and forecasts, 2013 – 2024 (USD Billion)
Chapter 6. Market Categorization 2: Regional Estimates & Trend Analysis, By Type
6.1. Nephrology and urology devices market shares by region, 2015 & 2024
6.2. North America
6.2.1. North America market estimates and forecasts, by type, 2013 – 2024 (USD Billion)
6.2.1.1. U.S. market estimates and forecasts
6.2.1.2. Canada market estimates and forecasts
6.3. Europe
6.3.1. Europe market estimates and forecasts, by type, 2013 – 2024 (USD Billion)
6.3.1.1. UK market estimates and forecasts
6.3.1.2. Germany market estimates and forecasts
6.4. Asia Pacific
6.4.1. Asia Pacific market estimates and forecasts, by type, 2013 – 2024 (USD Billion)
6.4.1.1. Japan market estimates and forecasts
6.4.1.2. China market estimates and forecasts
6.4.1.3. India market estimates and forecasts
6.5. Latin America
6.5.1. Latin America market estimates and forecasts, by type, 2013 – 2024 (USD Billion)
6.5.1.1. Brazil market estimates and forecasts
6.5.1.2. Mexico market estimates and forecasts
6.6. MEA
6.6.1. MEA market estimates and forecasts, by type, 2013 – 2024 (USD Billion)
6.6.1.1. South Africa market estimates and forecasts
Chapter 7. Competitive Landscape
7.1. Strategy framework
7.2. Market participation categorization
7.3. Company Profiles
7.3.1. Asahi Kasei Corporation
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. B.Braun Group
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Baxter International, Inc
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Boston Scientific Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. C.R. Bard, Inc
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Coloplast AS
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Cook Medical
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Dornier MedTech
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Fresenius Medical Care AG & Co. KGaA
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Nikkiso Co.Ltd.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Nipro Corporation
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. NxStage Medical, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Olympus Medical Systems
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Rockwell Medical Technologies, Inc.
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. Terumo Corporation
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Svenska Cellulosa Aktiebolaget (SCA)
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives
7.3.17. ONTEX International N.V.
7.3.17.1. Company overview
7.3.17.2. Financial performance
7.3.17.3. Product benchmarking
7.3.17.4. Strategic initiatives
7.3.18. Kimberly-Clark Corporation
7.3.18.1. Company overview
7.3.18.2. Financial performance
7.3.18.3. Product benchmarking
7.3.18.4. Strategic initiatives
7.3.19. First Quality Enterprises, Inc.
7.3.19.1. Company overview
7.3.19.2. Financial performance
7.3.19.3. Product benchmarking
7.3.19.4. Strategic initiatives
7.3.20. Teleflex Incorporated
7.3.20.1. Company overview
7.3.20.2. Financial performance
7.3.20.3. Product benchmarking
7.3.20.4. Strategic initiatives
7.3.21. Siemens Healthineers
7.3.21.1. Company overview
7.3.21.2. Financial performance
7.3.21.3. Product benchmarking
7.3.21.4. Strategic initiatives
7.3.22. Medtronic
7.3.22.1. Company overview
7.3.22.2. Financial performance
7.3.22.3. Product benchmarking
7.3.22.4. Strategic initiatives
7.3.23. Medline Industries, Inc.
7.3.23.1. Company overview
7.3.23.2. Financial performance
7.3.23.3. Product benchmarking
7.3.23.4. Strategic initiatives
7.3.24. STORZ Medical AG
7.3.24.1. Company overview
7.3.24.2. Financial performance
7.3.24.3. Product benchmarking
7.3.24.4. Strategic initiatives

List of Figures

FIG. 1 Market summary (USD Billion)
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 Nephrology and urology company market share, 2015
FIG. 8 Competitive Landscape Analysis, 2015
FIG. 9 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 10 Porter’s Five Forces Analysis
FIG. 11 Nephrology and urology devices market type outlook key takeaways
FIG. 12 Nephrology and urology devices market: Type movement analysis
FIG. 13 Global dialysis market, 2013 - 2024 (USD Billion)
FIG. 14 Global urinary stone market, 2013 - 2024 (USD Billion)
FIG. 15 Global urinary stents market, 2013 - 2024 (USD Billion)
FIG. 16 Global lithotripters market, 2013 - 2024 (USD Billion)
FIG. 17 Global urinary incontinence & pelvic organ prolapse market, 2013 - 2024 (USD Billion)
FIG. 18 Global sacral neuromodulation market, 2013 - 2024 (USD Billion)
FIG. 19 Global vaginal meshes & slings market, 2013 - 2024 (USD Billion)
FIG. 20 Global urethral inserts & pessaries market, 2013 - 2024 (USD Billion)
FIG. 21 Global benign prostatic hyperplasia market, 2013 - 2024 (USD Billion)
FIG. 22 Global catheter ablation market, 2013 - 2024 (USD Billion)
FIG. 23 Global prostatic stents market, 2013 - 2024 (USD Billion)
FIG. 24 Global endoscopy market, 2013 - 2024 (USD Billion)
FIG. 25 Global others market, 2013 - 2024 (USD Billion)
FIG. 26 Regional market place: Key takeaways
FIG. 27 Regional outlook, 2015 & 2024
FIG. 28 North America nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 29 U.S. nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 30 Canada nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 31 Europe nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 32 Germany nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 33 UK nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 34 Asia Pacific nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 35 Japan nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 36 China nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 37 India nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 38 Latin America nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 39 Brazil nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 40 Mexico nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 41 MEA nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 42 South Africa nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 43 Strategy framework
FIG. 44 Participant categorization

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 3 North America urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 4 North America urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 5 North America benign prostatic hyperplasia devices market, by type, 2013 - 2024 (USD Billion)
TABLE 6 U.S. nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 7 U.S. urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 8 U.S. urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 9 Canada nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 10 Canada urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 11 Canada urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 12 Europe nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 13 Europe urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 14 Europe urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 15 Germany nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 16 Germany urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 17 Germany urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 18 UK nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 19 UK urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 20 UK urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 21 Asia Pacific nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 22 Asia Pacific urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 23 Asia Pacific urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 24 Japan nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 25 Japan urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 26 Japan urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 27 China nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 28 China urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 29 China urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 30 India nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 31 India urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 32 India urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 33 Latin America nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 34 Latin America urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 35 Latin America urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 36 Brazil nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 37 Brazil urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 38 Brazil urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 39 Mexico nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 40 Mexico urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 41 Mexico urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 42 MEA nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 43 MEA urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 44 MEA urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 45 South Africa nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 46 South Africa urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 47 South Africa urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)

★調査レポート[腎臓および泌尿器機器の世界市場分析:タイプ別(透析、尿石、尿管ステント、石灰化装置、尿失禁および骨盤臓器脱落、仙骨神経調節、膣メッシュおよびスリング、尿道挿入物およびペッサリー、良性前立腺肥大症、カテーテルアブレーション、前立腺ステント、内視鏡)、セグメント予測] (コード:GVIEW707577)販売に関する免責事項を必ずご確認ください。
★調査レポート[腎臓および泌尿器機器の世界市場分析:タイプ別(透析、尿石、尿管ステント、石灰化装置、尿失禁および骨盤臓器脱落、仙骨神経調節、膣メッシュおよびスリング、尿道挿入物およびペッサリー、良性前立腺肥大症、カテーテルアブレーション、前立腺ステント、内視鏡)、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆